Home › Trial NCT03912389
Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC
- Trial IDNCT03912389
- StatusUnknown
- PhasePhase 3
- Study typeInterventional
- SponsorBiocad
- Enrollment292
- Start date2019-06-01
- ConditionsNon-Squamous Non-Small Cell Neoplasm of Lung
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.